112 type B and C lesions (diffuse narrowing, tapering and obliteration), 25% were In primary vessels, 44% in second. ary vessels and 31% In tertiary branches (p < 0 .05 for patients with transplant coronary vascular disease versus patients with nentransplant coronary artery disease). Total vessel activation was found in proximal or middle vessel segments In %% and distally in 4% of patients with "ordinary" coronary artery disease versus 49% distally In patients with transplant coronary disease (p < 0 .002), In the presence of total vessel occlusion, collateral vessels were poor orabsent 1. 92% of transplant versus 7% of noniransplant patients wish coronary disease (p < 0.002).
Therefore, coronary artery disease In transplant patients represents a mlature of typical atheromatms Wants and unique trnspast-related progressive distal obliterative dis . ease that occurs without collateral vessel development .
(J Ana Cod Cordite! 1988;12.334-40) cardiac innervation makes transplant recipients unable to experience angina pectoris, the first sign of transplant coro . nary disease can be the appearance of silent myocardial infarction on the electrocardiogram, development of congestive heart failure or ventricular arrhythmia leading to sudden death. Because the disease can be clinically silent and can progress rapidly in many cases, annual coronary arledograms have been performed as a matter of policy in all heart transplant patients at Stanford . A total of 634 of these sequential coronary arteriograms were available for analysis . The purposes of this study are 1) to evaluate the prevalence of accelerates coronary vascular disease in the cardiac allograft, and 2) to study the characteristic angiographic features of this process and delineate its differences from "ordinary" (nontransplant) coronary angiographic lesions .
Methods
Study patients . The patient data base for this study consisted of 221 heart transplant patients (including 13 heart and lung transplant patients) and 32 nontransplant patients with coronary artery disease diagnosed by standard clinical and angiographic criteria .
The transplant recipients were classified into two groups: The first group consisted of 132 patients (including 13 heart and lung transplant recipients) who underwent heart transplantation after 1979, survived at least 1 year and had annual follow-up arteriography for I to 5 years (mean 2 .4) . The second group consisted of 37 patients who had transplant procedures before 1979, survived at least I year and had annual coronary angiography for a mean of 5 .3 years during which development of coronary vascular disease was documented . An additional 52 heart transplant patients operated on before 1979 who survived at least 1 year without known development of coronary disease were excluded because many of their early arteriograms were not available for comparison with later studies .
A third group consisted of 32 nontransplant patients with clinically stable, medically treated coronary artery disease who were participating in a separate research protocol and who had both baseline arteriograms and repeat studies performed 5 years later .
Cardiac catheterization. All patients were evaluated with left and right heart catheterization and selective coronary arteriography using the percutaneous femoral approach. Left ventricular cineangiography was performed in alt patients . Cardiac output was determined by the Fick method. The procedures for cardiac catheterization were explained to all patients and informed consent was obtained under Stanford Institutional Review Board guidelines .
Coraoary arterlogiaphy. On the basis of a pilot project reviewing serial arteriograms in 15 transplant hearts with coronary disease, a list of descriptors for various coronary morphologic abnormalities and collateral vessel qualities was developed. These descriptors were used in interpreting the arteriograms of both transplant and nontransplant patients with coronary diseases . The angiographic findings were reviewed by two angiographers independently, and a consensus on interpretation was reached . All arteriographic interpretations were based on side by side comparisons of serial films .
The following anatomic abnormalities were coded ( Fig.  1 ):Type A, discrete stenoses, tubular stenoses and multiple stenoses in the proximal, middle or distal segment branches ; type B, diffuse concentric narrowing with onset in mid to distal artery; type B I , proximal vessel maintaining normal diameter with abrupt onset of distal concentric narrowing and obliteration; type B2, gradual transition from normal proximal vessel with tapering concentric narrowing gradually increasing in severity distally ; and type C, diseased vessels, diffusely irregular, that have lost small branches ; they do not taper normally but exhibit terminations that are often nontapered, squared off and end abruptly. GAO Definition of arterial vessels . These anatomic abnormalities were identified as being in primary, secondary or tertiary vessels.
Primary vessels. These are the large epicardial vessels, including the left main, left anterior descending, left circumflex and right coronary arteries.
Secondary vessels. These are the major branch vessels of the primary epicardial coronary vessels . The major diagonal, marginal . posterior descending and posterolateral branches constitute the secondary branches .
Tertiary vessels. These are angiographically visible small branches of both primary and secondary vessels . They are larger in diameter than the fine arteriolar or capillary network, but are short in length and subtend relatively small areas of myocardium.
Both primary and secondary vessels are of sufficient length to divide into proximal, middle and distal segments . Segmentation for primary vessels was based on nomenclature used in the Coronary Artery Surgery Study (5) ; that for secondary vessels was based on equal subdivisions.
Criteria for collateral vend qualIty . Good: The collateral channels are discrete and visible . Collateralized vessels are visualized so that walls and lesions can be identified. Fair: The proximal or distal segments of collateralized vessels are filled, but not enough to visual anatomic detail . Poor : The collateralized vessels are faintly filled . None: There is no visualization of the main trunk of occluded vessel other than scattered tiny disconnected faint twigs .
Statistical Andynlw All data are presented as mean ± I SD . Comparisons among groups were analyzed with the two-sample Student's t test for differences in proportion and means, respectively . The chi-square test was used to assess intergroup differences in distribution of lesions, quality of collateral supply and incidence of transplant coronary disease . A difference of p < 0 .05 was considered statistically significant . 
Results
Prevalence of transplant coronary vascular disease (Table  1) . Forty-four (33%) of 132 heart transplant patients operated on after 1979 showed angiographic evidence of transplant coronary disease. In patients operated on before 1979, 37 (41 .5%) of 89 had documented coronary artery lesions . The prevalence of coronary disease was higher in the available patients in the pre-1979 group than in patients in the post-1979 group (p > 0 .05) ; this difference is at least in ;part explained by the longer follow-up period for the early group .
Arteriographic findings of transplant coronary vascular disease. For morphologic analysis, the 37 pre-1979 transplant patients with angiographic coronary vascular disease were included with the 44 post-1979 transplant patients who also exhibited coronary disease . To demonstrate time of initial detection of coronary disease in these 81 transplant recipients, cumulative occurrence rates for transplant coronary disease in relation to time after surgery are shown in Analysis of the distribution of lesions revealed a significant difference between transplant and nontransplant patients ( Figure 4 . Left coronary artery aneriogram shows essentially normal arstomy I year after cardiac transplantation (left). Four years after transplantation (right), the arteriogrom shows a B, lesion in the distal left anterior descending coronary artery and both B, and C lesions in the distal branches of the obtuse marginal artery (arrows).
Comparison of the site of total occlusion of vessels and tire quality of collateral vessel formation also revealed striking differences between the two groups (Table 4) . In transplant patients, 16 (43%) of 37 vessels were occluded proximally and 18 (49%) of 37 vessels were occluded in their distal segments . In the nontransplant patients with coronary artery disease, 21 (72%) of 29 vessels had occluded in the proximal segment and only 1 (3.5%) of 29 vessels had occluded distally .
Collateral vessel formation was very poor !it transplant patients (Table 5) . Collateral vessels to occluded vessels could not be seen at all in 29 (78%) of the 37 arteries, and S (14%) of the 37 occluded vessels had only faintly filled collateralized vessels . In contrast, in the nontransplant group with coronary artery disease, 22 (76%) of 29 occluded vessels had good collateral vessels and 5 (17%) of 29 occluded vessels had fair collateral vessels . In no instance were collateral vessels absent .
Discussion
Prevalence of coronary vascular disease . A very diffuse and often rapidly progressive type of occlusive coronary vascular disease has been found to affect a substantial number of cardiac allograft recipients in the late postoperative period. As survival after cardiac transplantation improves because of increasingly successful management of Figure 5 . Left coronary artery arteriogram shows essentially normal anatomy I year after cardiac transplantation (left). Three years after transplantation (right), the arteriogram shows type B, lesions in the left circumflex and marginal coronary arteries and a type B, lesion in the distal anterior descending coronary artery.
GAO LT AL.
CORONARY DISEASE IN HEART TRANSPLANT PATIENTS
Out 'Iron I" VLMK allograft rejection and infectious complications, accelerated coronary vascular disease or allograf atherosckrosis may constitute the major limitation to long-term survival forheart transplant recipients (6) .
The incidence of angiogenphic coronary vascular disease in heart transplant recipients was first reported by the Stanford group in 1981 (2) to be approximately 40% (21 of 85 patients) at 5 years after transplantation, More recent data from our group (7) suggest that this incidence has not changed since the introduction of cyclosporine-based immunosuppression in 1980. The more exhaustive review reported here confirms the previously described high incidence of the disease . It is worthwhile to note here that these prevalence figures denote only the angiographic documentation of some disease but not its severity or the existence of clinical sequelae . Many of these patients have apparently mild disease with as yet no detectable clinical sequelae .
Arteriographic findings . Analysis of coronary arteriograms of affected cardiac allografts presented here reveals unique morphologic features of this disease consisting of diffuse concentric narrowing, prominent in middle to distal vessels, with distal vessel obliteration . The vessels narrow distally in one of three ways : 1) gradual transition from normal proximal vessel with smooth concentric tapering, the distal vessel having some residual lumen (type B 2); 2) abrupt narrowing with concentrically narrowed and obliterated distat vessel (termed "pruning"), with only faintly visualized Figure 6 . The left coronary artery arteriogran shows essentially normal anatomy I year after cardiac transplantation (top). Pour years after transplantation (bottom), the arteriogram shows type B, lesions in the obtuse marginal branch . channels remaining (type 8,) ; and 3) narrowed irregular distal branches with loss of small branches (type C) . These type C vessels often contain some ectahc areas following areas of narrowing ; their terminations are often nontapered and squared off and end abruptly. In terminal branch coronary vessel segments, type C lesions predominate, whereas in conduit coronary segments, type A lesions predominate . There is a striking lack of development of collateral blood supply to affected vessels, with supply graded as poor or absent in 92% of the totally occluded vessels in 20 transplant patients with coronary diseases. Lesion type : A = discrete smnada, B, = concentric-sharp taper, B, _ -centric-gradual taper, C = distal obliteration . CAD = nontrenrplent coromry, artery disease ; N8 = not significant; TxCVD = transplant coronary vascular disease. phic features in typical nontransplant patients with coronary artery disease . However, a number of typical proximal discrete stenoses similar to those in nontransplant patients were also noted . Thus, angiographic findings in transplant coronary vascular disease are a mixture of both typical atherosclerotic lesions and unusual, presumably transplantation-related, progressive diffuse distal obliterative disease without collateral vessel development . Abbreviations as in Table 2 .
Morphologic changes . The angiographic features of transplant coronary disease described here can be related to histopathologic changes described in explanted allografts or allografts examined at autopsy (8-10) . The histopathologic changes of atherosclerosis in human cardiac allograft recipients were first described in autopsy findings from 12 patients. These changes consisted of a circumferential and longitudinal increase in intimalfibrous tissue and myointimal cells limited to coronary arteries with muscular media and not present in arterioles and veins . The thickness of the intima was roughly proportional to the age of the graft, with some thickening developing as early as 9 days ; thickening was present in six of seven allografts from patients surviving >1 month. Of note, purely proliferative intimal lesions were seen in grafts studied early after implantation, and large numbers of lipophages and lipid droplets appeared in grafts studied later (9,1). Atherosclerotic lesions in major coronary arteries of patients who die from transplant coronary vascular disease are histopathologically similar in composition to those occurring in nontransplant coronary artery disease (8) but differ in their diffuse distribution, correlating well with the arteriographic features of transplant coronary disease we have described. Follow-up and therapy . Because of the longitudinal and concentric distribution of transplant coronary vascular disease, it is important to compare serial angiogroms to detect a general decrease in caliber of vessels, "dropout" of Abbreviations as in Table 2 .
branches or distal "pruning" of vessels . Precise quantitation of progressive concentric narrowing may be done by serial quantitative arteriography, and prospective studies with this technique are underway in our institution. The Stanford group initially decided to perform angiograms in this patient group at I year intervals . Because of the abrupt occurrence of severe coronary disease within a single year in a number of these patients, this interval has never been increased. The diffuse distribution and rapid progression of transplant coronary disease makes these patients poor candidates for conventional therapy with angioplasty or coronary artery bypass graft surgory. Filective retransplantation, currently the only recognized treatment for severe stages of transplant coronary disease, is offered to patients believed to be at high risk of death from this disease . Pathogenesis of transplant coronary vascular disease. Despite many investigations (12, 13) , the pathogenesis of transplant coronary disease remains undetermined, although some type of vascular immunologic injury is presumed by most to be involved . The lesions of experimental cardiac allograft atherosclerosis were first described at the microscopic level (14) in material from canine cardiac allografts ; that study also noted a time-related occurrence of coronary intimal thickening, not correlated with acute allograft rejection, which was present in almost all the large coronary arteries in dogs surviving >1 year . Other investigators have demonstrated the induction of occlusive allograf coronary vascular disease in rat (13, 15) and rabbit (16) models . Relating these observations to the histopatholrgic change in human allograft atherosclerosis has led to the assumption that initial proliferative intimal lesions eventually become infiltrated with lipid and, subsequently, fibrous scoring additionally leads to the nonspecific appearance of ordinary atherosclerotic disease. Accelerated vascular disease has been observed in other organ grafts (17, 18) . Histopathologic changes described in the arteries of renal grafts include fibroproliferative lesions in the intima, necrosis of the media and degeneration of smooth muscle cells . The arterial intima is thickened by myofibroblast proliferation, which can lead to severe narrowing or even occlusion of the arterial lumen and can result in renal infarctions (19, 20 The extent to which immunologic injury or steroid use contributes to transplant coronary vascular disease is uncertain . Coronary atherosclerosis and myocardial infarction associated with systemic Inputs erythematosus in young adults have been reported (21, 22) . Thirty-six patients with systemic ]opus erythematosus who had received long-term corticosteroid treatment and 20 patients who did not were compared in one study. Twenty (56%) of the 36 corticosteroid-treated patients showed intramural coronary artery narrowing . These vessels were narrowed by fibrous intimal proliferation and sometimes the endothelial cells were degenerated . The walls of these vessels were occasionally necrotic. Extramural coronary artery narrowing by >50% was noted in 9 (25%) of 36 patients. Atherosclerotic plaques blocked these vessels (23) .
High levels of serum lipids are known to correlate with increased incidence of ordinary coronary artery disease and could be contributing factors in the pathogenesis of transplant coronary vascular disease. Elevated levels of serum 
